Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions

Toxicology Letters

Volumn 210, Issue 3, 2012, Pages 360-365

  Butenhoff, John L ^a   Pieterman, Elsbeth ^b   Ehresman, David J ^a   Gorman, Gregory S ^c   Olsen, Geary W ^a   Chang, Shu Ching ^a   Princen, Hans M G ^b  

^a 3M COMPANY   (United States)

^b TNO   (Netherlands)

^c SAMFORD UNIVERSITY   (United States)

Author keywords

Cholesterol; Fractionation; Lipoprotein; Perfluorooctanesulfonate; Perfluorooctanoate

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; VERY LOW DENSITY LIPOPROTEIN; ALKANESULFONIC ACID; FLUOROCARBON; OCTANOIC ACID DERIVATIVE;

ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; ULTRAFILTRATION; BLOOD; CROSS-SECTIONAL STUDY; DENSITY GRADIENT CENTRIFUGATION; DOSE RESPONSE; PROTEIN BINDING;

ALKANESULFONIC ACIDS; CENTRIFUGATION, DENSITY GRADIENT; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROCARBONS; HUMANS; LIPOPROTEINS; OCTANOIC ACIDS; PROTEIN BINDING;

EID: 84858983358     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.02.013     Document Type: Article

References (29)

1. *3-Leiden CETP mice. Toxicol. Sci. 2011, 123:290-303.
2. Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., Jung R., Kennedy G., Lieder P., Olsen G., Thomford P. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol. Sci. 2002, 69:244-257.
3. Butenhoff J.L., Kennedy G.L., Hinderliter P.M., Lieder P.H., Jung R., Hansen K.J., Gorman G.S., Noker P.E., Thomford P.J. Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol. Sci. 2004, 82:394-406.
4. Butenhoff J.L., Chang S.C., Olsen G.W., Thomford P.J. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 2012, 293:1-15.
5. Costa G., Sartori S., Consonni D. Thirty years of medical surveillance in perfluorooctanoic acid production workers. J. Occup. Environ. Med. 2009, 51:364-372.
6. Curran I., Hierlihy S.L., Liston V., Pantazopoulos P., Nunnikhoven A., Tittlemier S., Barker M., Trick K., Bondy G. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS). J. Toxicol. Environ. Health A 2008, 71:1526-1541.
7. Ehresman D.J., Froehlich J.W., Olsen G.W., Chang S.C., Butenhoff J.L. Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals. Environ. Res. 2007, 103:176-184.
8. Elcombe C.R., Elcombe B.M., Foster J.R., Farrar D.G., Jung R., Chang S.C., Kennedy G.L., Butenhoff J.L. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats following dietary exposure to ammonium perfluorooctanoate occurs through increased activation of the xenosensor nuclear receptors PPARα and CAR/PXR. Arch. Toxicol. 2010, 84:787-798.
9. Elcombe C.R., Elcombe B.M., Foster J.R., Chang S.-C., Ehresman D.J., Butenhoff J.L. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. Toxicology 2012, 293:16-29.
10. Frisbee S.J., Shankar A., Knox S.S., Steenland K., Savitz D.A., Fletcher T., Ducatman A. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 health project. Arch. Pediatr. Adolesc. Med. 2010, 164:860-869.
11. Han X., Snow T.A., Kemper R.A., Jepson G.W. Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem. Res. Toxicol. 2003, 16:775-781.
12. Haughom B., Spydevold O. The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim. Biophys. Acta 1992, 1128:65-72.
13. Loveless S.E., Finlay C., Everds N.E., Frame S.R., Gillies P.J., O'Connor J.C., Powley C.R., Kennedy G.L. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 2006, 220:203-217.
14. MacPherson I.R., Bissett D., Petty R.D., Tait B., Samuel L.M., MacDonals J., Smith M., Birse-Archbold J.A., Barnett A.L., Wolf C.R., Elcombe C.R., Jeynes-Ellis A., Evans T.R.J. A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer. J. Clin. Oncol. 2011, 29.
15. Nelson J.W., Hatch E.E., Webster T.F. Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population. Environ. Health Perspect. 2010, 118:197-202.
16. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 2000, 23:603-620.
17. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 2003, 45:260-270.
18. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health 2007, 81:231-246.
19. Olsen, G.W., Ehresman, D.J., Buehrer, B.D., Gibson, B.A., Butenhoff, J.L., Zobel, L.R., 2012. Longitudinal assessment of lipid and hepatic clinical parameters in workers involved with the demolition of PFOA and PFOS manufacturing facilities. J. Occup. Environ. Med., in press.
20. Redgrave T.G., Roberts D.C.K., West C.E. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 1975, 65:42-49.
21. Sakr C.J., Kreckmann K.H., Green J.W., Gillies P.J., Reynolds J.L., Leonard R.C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or apfo) as part of a general health survey in a cohort of occupationally exposed workers. J. Occup. Environ. Med. 2007, 49:1086-1096.
22. Sakr C.J., Leonard R.C., Kreckmann K.H., Slade M.D., Cullen M.R. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J. Occup. Environ. Med. 2007, 49:872-879.
23. Salvalaglio M., Muscionico I., Cavallotti C. Determination of energies and sites of binding of PFOA and PFOS to human serum albumin. J. Phys. Chem. B 2010, 114:14860-14874.
24. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 2002, 68:249-264.
25. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., Butenhoff J.L. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117-131.
26. Steenland K., Tinker S., Frisbee S., Ducatman A., Vaccarino V. Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am. J. Epidemiol. 2009, 170:1268-1278.
27. Sundström M., Ehresman D.J., Bignert A., Butenhoff J.L., Olsen G.W., Chang S.C., Bergman å. A temporal trend study (1972-2008) of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in pooled human milk samples from Stockholm, Sweden. Environ. Int. 2011, 37:178-183.
28. Turley S.D., Spady D.K., Dietschy J.M. Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey. J. Lipid Res. 1995, 36:67-79.
29. Yee M.S., Pavitt D.V., Tan T., Venkatesan S., Godsland I.F., Richmond W., Johnston D.G. Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis. J. Lipid Res. 2008, 49:1364-1371.